VIJOICE
Novartis Ag
The mark consists of the wording "VIJOICE" in lilac stylized font with seven circles in shades of green over the letters "ijoic" with circles making the dots over the letters "i" and "j" and with the circles changing in size and color from left to right from large to small and from green to light green.
Mark For: VIJOICE® trademark registration is intended to cover the categories of
>The colors lilac, green and light green are claimed as a feature of the mark. The mark consists of the wording "VIJOICE" in lilac stylized font with seven circles in shades of green over the letters "ijoic" with circles making the dots over the letters "i" and "j" and with the circles changing in size and color from left to right from large to small and from green to light green.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79281646 |
| Registration Number | 6150249 |
| Mark Literal Elements | VIJOICE |
| Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
| Mark Type | TRADEMARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-09-15 |
| Basis | 66(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | Yes |
| Current Basis | No |
| No Basis | No |
Timeline
| 2020-01-28 | Application Filed |
| 2020-03-26 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-03-26 | Status: Live/Pending |
| 2020-04-03 | Transaction Date |
| 2020-06-30 | Published |
| 2020-09-15 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-09-15 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-09-15 | Trademark Registered |
| 2025-09-15 | Maintenance Early File Date |
| 2026-09-15 | Maintenance On Time Date |
| 2027-03-15 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  NOVARTIS AG |
| Address | CH-4002 Basel SWITZERLAND |
| Legal Entity Type | Aktiengesellschaft |
| Legal Entity State | SWITZERLAND |
Documents
 Application | MULTI | 2020-03-26 |
 Drawing | JPEG | 2020-03-26 |
| Filing Receipt Trademark Application | XML | 2020-04-07 |
| Offc Action Outgoing | XML | 2020-04-17 |
| XSearch Search Summary | XML | 2020-04-17 |
| IB-1rst Refusal Note | XML | 2020-05-04 |
| Change Address or Representation Form | XML | 2020-05-15 |
| Response to Office Action | APPLICATION/XML | 2020-05-17 |
| Amendment and Mail Process Complete | MULTI | 2020-05-19 |
| IB-Processed Transaction | XML | 2020-05-21 |
| Examiners Amendment | XML | 2020-05-27 |
| Notation to File | XML | 2020-05-27 |
| Amendment and Mail Process Complete | MULTI | 2020-05-28 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-05-28 |
| Notice of Publication | XML | 2020-06-10 |
| Notification Of Notice of Publication | XML | 2020-06-10 |
| OG Publication Confirmation | XML | 2020-06-30 |
| Registration Certificate | 2020-09-15 | |
| IB-Generic Notification To | MULTI | 2021-01-02 |
| IB-Processed Transaction | XML | 2021-01-28 |
Design Search Codes
| 26.01.31 | Circles |
| 260121 | Circles that are totally or partially shaded. |
| 260131 | Circles |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) lilac and green is/are claimed as a feature of the mark. |
| CC0000 | The colors lilac, green and light green are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-01-30 | |
| GENERIC MADRID TRANSACTION SENT TO IB | 2021-01-02 | |
| GENERIC MADRID TRANSACTION CREATED | 2021-01-02 | 76533 |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-12-15 | |
| REGISTERED-PRINCIPAL REGISTER | 2020-09-15 | |
| PUBLISHED FOR OPPOSITION | 2020-06-30 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-06-30 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-06-10 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-05-27 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2020-05-27 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2020-05-27 | 94660 |
| EXAMINER'S AMENDMENT ENTERED | 2020-05-27 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-27 | |
| REFUSAL PROCESSED BY IB | 2020-05-23 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-18 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-17 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-17 | 88889 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-05-15 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-05-15 | |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-05-15 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-05-15 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-05-15 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-05-15 | 88888 |
| REFUSAL PROCESSED BY MPU | 2020-05-04 | 67445 |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-05-04 | |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-04-18 | |
| NON-FINAL ACTION WRITTEN | 2020-04-17 | 94660 |
| ASSIGNED TO EXAMINER | 2020-04-15 | 94660 |
| APPLICATION FILING RECEIPT MAILED | 2020-04-07 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-04-03 | |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2020-03-31 | 72629 |
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-03-26 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VIJOICE 79352744 not registered Live/Pending |
NOVARTIS AG 2022-09-13 |
 VIJOICE 79284023 not registered Live/Pending |
NOVARTIS AG 2020-03-10 |
 VIJOICE 79281646 not registered Live/Pending |
NOVARTIS AG 2020-01-28 |
 VIJOICE 79249982 not registered Live/Pending |
NOVARTIS AG 2018-12-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 